在混乱定义的一年中，吉利德（Gilead）的团队与时间竞争，并在障碍物中推动了障碍，以帮助在199年大流行中对患者进行潜在治疗。

In the first episode of our new “Possible” documentary series, learn how Anu Osinusi, an infectious disease physician who leads the company’s Emerging and Respiratory Viruses group, worked with colleagues across the company, regulatory authorities and external partners to get an investigational antiviral treatment to a patient in Seattle. In the process, the Gilead teams demonstrated how employees create possible.

观看我们“可能”系列的其他情节这里。